How To Build A Successful Career As A Medical Affairs Professional
In this session, you will hear “insider tips” from three senior-level Medical Affairs leaders from leading multinational biopharma companies.
Podcast: European Union Medical Device Regulations (EUMDR)
This podcast series discusses the basics of EUMDR, what this means more globally (FDA, CFDA) and finally – how we can view this as the golden opportunity to elevate the science of our products and communicate a compelling medical value proposition.
Launch Readiness 2020: Ensuring Strategy And Value From Global To Local Perspectives
This MAPS podcast introduces listeners to social listening to gather insights and discusses implementation, value and technologies.
Podcast: Stakeholder Expectations in the Evolving Healthcare Landscape
In this podcast series, panelists discuss the volatile, uncertain, complex and ambiguous (VUCA) environment that necessitates change in culture, leadership and strategy in life sciences companies. Collaboration with stakeholders are more important than ever and the real value lies in the connections between stakeholder groups. Clarity on who future internal and external stakeholders are is important for Medical Affairs functions.
Podcast: Transitioning between Pharma and MedTech…And Vice Versa
In this podcast, senior leaders outline the core similarities and differences between Pharma and MedTech; assess the pros and cons of a potential move from Pharma into MedTech; and describe the practical changes required to anticipate and prepare for such a career move.
Purpose-driven culture: How to make an impact in a value-driven world
Executive Vice President & CMO, UCB, Iris Loew-Friedrich discusses the importance of a purpose-driven culture to employee engagement
The Rise and Rise of Medical
In My Journey: The Rise & Rise of Medical, Dr. Ameet Nathwani discusses the need to define and measure our contribution, and why we need to join together as a community to shape the future of healthcare.
Digital Health: The Road Ahead for Medical Affairs
In “Digital Health: The Road Ahead for Medical Affairs,” CMO and Head of Medical Affairs & Pharmacovigilance at Bayer, Mike Devoy discusses Medical Affairs’ unique understanding of how value can be created and delivered, and the key role it plays in developing the evidence and solutions around that value in collaboration with internal and external partners.
Clinical Statistics for Non-Statisticians (Part 2 of 2)
Part 2 of this series will discuss statistical analysis in clinical trials including null/alternative hypotheses; statistical assumptions (type I error, significance level, type II error, statistical power); hypothesis testing; Statistics used in RCTs, including type of outcome measures, analysis of time-to-event variables (plotting and interpretation of Kaplan-Meier curves).
A Global Perspective on Conducting Early Access Programs
Early Access includes a variety of programs by which pharmaceutical companies make investigational therapies available to patients with life-threatening diseases. These patients have either exhausted available treatments or have no approved options. This presentation will review the processes and procedures to consider in the implementation of an Early Access Program and explore the opportunities and challenges posed therein.